CUAMC
EIGR
China Universal Asset Management Company’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-1,133
| Closed | -$346 | – | 494 |
|
|
2023
Q3 | $346 | Buy |
1,133
+553
| +95% | +$169 | ﹤0.01% | 446 |
|
|
2023
Q2 | $408 | Sell |
580
-17
| -3% | -$12 | ﹤0.01% | 451 |
|
|
2023
Q1 | $535 | Buy |
597
+150
| +34% | +$134 | ﹤0.01% | 446 |
|
|
2022
Q4 | $527 | Buy |
447
+35
| +8% | +$41 | ﹤0.01% | 390 |
|
|
2022
Q3 | $3K | Buy |
+412
| New | +$3K | ﹤0.01% | 341 |
|